retatrutide podcast The biggest headline may not be the weight loss. It may be the word “biologic.”, Lilly says it plans to submit retatrutide through a Biologics License Application, or BLA, in Q1 2027, a Retatru-what?!, This week on the

Loos MF (2021) Modeling primary carnitine deficiency-mediated dilated cardiomyopathy in engineered heart tissue format, doctoralThesis, Staats- und Universittsbibliothek Hamburg Carl von Ossietzky

This research paper aims to provide a comprehensive analysis of LL-37, elucidating its biochemical properties, antimicrobial activity, immunomodulatory effects, and potential therapeutic applications

Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, Blom HJ (2006) Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis

Third and people forget this one copper adds up